Prophylactic Use of APRV Before Extubation in Morbidly Obese Patients After Cardiac Surgery.
APRV-OBESE-CS
Prophylactic Use of Airway Pressure Release Ventilation (APRV) Prior to Extubation in Morbidly Obese Patients Undergoing Elective Cardiac Surgery: Impact on Pulmonary Function, Oxygenation, and ICU Outcomes.
1 other identifier
interventional
180
0 countries
N/A
Brief Summary
Morbidly obese patients undergoing open heart surgery are at increased risk of breathing problems after removal of the breathing tube due to reduced lung function and chest wall restriction following surgery. These complications may result in poor oxygenation, respiratory failure, and prolonged ICU stay. Airway Pressure Release Ventilation (APRV) is a mechanical ventilation mode that improves lung recruitment and oxygenation. This study aims to evaluate whether the prophylactic use of APRV after ICU admission, compared with conventional lung-protective mechanical ventilation, improves oxygenation, lung function, and ICU outcomes in morbidly obese patients undergoing elective cardiac surgery. Patients will be randomly assigned to receive either APRV or conventional ventilation during postoperative mechanical ventilation, followed by standard weaning and extubation. Outcomes include oxygenation index, lung ultrasound findings, need for reintubation, and ICU clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedFirst Posted
Study publicly available on registry
February 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
February 13, 2026
February 1, 2026
8 months
January 24, 2026
February 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oxygenation Index (OI)
The oxygenation index will be used as a quantitative measure of pulmonary oxygenation efficiency. It will be calculated using the formula: OI = (Mean Airway Pressure × FiO₂ × 100) / PaO₂. Changes in oxygenation index will be assessed to compare the effect of prophylactic APRV versus conventional lung-protective ventilation on pulmonary function in morbidly obese patients after elective cardiac surgery.
o Immediately before APRV initiation o 1 hour before extubation o 1 hour post-extubation o 6 hours post extubation o 24 hours post extubation
Secondary Outcomes (7)
Lung Ultrasound Score (LUS)
o 1 hour before extubation o 6 hours post extubation
PaO₂/FiO₂ Ratio
o Immediately before APRV initiation o 1 hour before extubation o 1 hour post-extubation o 6 hours post extubation o 24 hours post extubation
Reintubation Rate
Within 48 hours after extubation
Duration of Mechanical Ventilation
From ICU admission until successful extubation, assessed up to 24 hours
Incidence of Post-Extubation Pulmonary Complications
Within 48 hours post-extubation
- +2 more secondary outcomes
Study Arms (2)
APRV Ventilation Strategy Group
EXPERIMENTALIntervention Name: Airway Pressure Release Ventilation (APRV) Patients will receive airway pressure release ventilation immediately upon admission to the intensive care unit following elective cardiac surgery. APRV will be applied as the primary ventilatory mode until the patient fulfills predefined extubation readiness criteria. Prior to extubation, patients will be transitioned to continuous positive airway pressure (CPAP) with pressure support or a T-piece trial for 15-30 minutes according to ICU protocol.
Conventional Lung-Protective Ventilation Group
ACTIVE COMPARATORPatients will receive conventional lung-protective mechanical ventilation using synchronized intermittent mandatory ventilation (SIMV) in volume-controlled mode with a tidal volume of 6-8 mL/kg of ideal body weight and high positive end-expiratory pressure upon admission to the intensive care unit. Ventilation will be continued until extubation readiness criteria are met, followed by a CPAP with pressure support or T-piece trial for 15-30 minutes prior to extubation.
Interventions
Patients will be ventilated using the Airway Pressure Release Ventilation (APRV) mode immediately upon ICU admission. This mode will be maintained throughout the postoperative period until the patient meets the clinical criteria for extubation. with the following standardized steps: Initial APRV Settings * P High: 20-25 cm H₂O * P Low: 0 cm H₂O * T High: 4.0-6.0 seconds * T Low: 0.5-0.8 seconds * FiO₂: Adjusted to maintain SpO₂ \>92% Note: P High may be titrated according to patient tolerance, Mean airway pressure (MAP), and plateau pressures. T Low is set to terminate expiratory flow at 50-75% to preserve lung recruitment. Weaning/Transition from APRV to Extubation Once oxygenation and ventilation criteria are met: * T High will be gradually increased (to ≥8 sec) and P High decreased (to 10-15 cm H₂O) * Then transition to CPAP/PS for 15-30 minutes Final decision for extubation will be based on successful spontaneous breathing trial (SBT) (RSBI \< 105) and clinical readiness
Patients will be ventilated using the SIMV Volume-Controlled mode with lung-protective strategies: * Tidal volume: 6-8 mL/kg of Ideal Body Weight (IBW) * PEEP: Set at 8-12 cm H₂O, individualized based on oxygenation status * Respiratory rate: Adjusted to maintain normocapnia, typically starting from 12-18 breaths per minute * FiO₂: Titrated to maintain SpO₂ \> 92% * Also transition to CPAP/PS for 15-30 minutes as a transition before extubation will be applied.
Eligibility Criteria
You may qualify if:
- Adult patients aged 18-65 year of both sex.
- Morbidly obese patients (body mass index ≥ 40 kg/m² or ≥ 35 kg/m² with obesity-related comorbidities)
- Scheduled for elective cardiac surgery (CABG, valve, or combined) requiring cardiopulmonary bypass
- Planned postoperative admission to the cardiac surgical intensive care unit
- Patients eligible for mechanical ventilation with planned early extubation within 6-12 hours postoperatively
- Ability to provide written informed consent
You may not qualify if:
- Severe pulmonary disease (e.g., COPD GOLD III/IV, home oxygen therapy, and pulmonary fibrosis).
- Patients with history of previous spontaneous pneumothorax or postoperative pneumothorax.
- Intracranial hypertension or contraindication to APRV. Hemodynamically unstable on admission (MAP less than 65 mmHg) Vasopressor/inotropic score (VIS) more than 10 Requirement for postoperative extracorporeal membrane oxygenation (ECMO) or intra-aortic balloon pump (IABP).
- Inability to obtain informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aya M Abbas, M.B.B.CH., M.Sc
Ain Shams University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2026
First Posted
February 13, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
February 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- before 12/2026
- Access Criteria
- free
All data will be shared once study is completed